Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022 Eiki IchiharaNobuaki OchiToshio Kubo Special Article 14 February 2024 Pages: 355 - 362
Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021 Hidekatsu NakaiTakahiro HigashiNoriomi Matsumura Cancer Statistics 21 February 2024 Pages: 363 - 371
Analgesic efficacy and safety of percutaneous thermal ablation plus cementoplasty for painful bone metastases: a systematic review and meta-analysis Tomohiro MatsumotoRika YoshimatsuTakuji Yamagami Original Article 13 January 2024 Pages: 372 - 385
Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study Yuki KatsuyaTatsuya YoshidaNoboru Yamamoto Original Article Open access 21 February 2024 Pages: 386 - 397
Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study Shigeki KataokaYoshitaka NishikawaManabu Muto Original Article 14 February 2024 Pages: 398 - 406
Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a Cancer-VTE Registry subanalysis Mashio NakamuraMasato SakonMasataka Ikeda Original Article Open access 02 March 2024 Pages: 407 - 416
Financial toxicity and patient experience associated with financial burden of molecular-targeted and immune therapies for cancer: an observational study under public health insurance Sena YamamotoChiharu KondohHarue Arao Original Article Open access 24 February 2024 Pages: 417 - 426
Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with HER2-enriched breast cancer Yang LiJun QinXing Sun Original Article 27 February 2024 Pages: 427 - 441
Abnormal activation of RFC3, A YAP1/TEAD downstream target, promotes gastric cancer progression Zijun GuoLin Guo Original Article 21 February 2024 Pages: 442 - 455
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan Junji FuruseFumihiko OsugiToshimitsu Endo Original Article Open access 14 February 2024 Pages: 456 - 463
Hydronephrosis severity as a predictor of postoperative renal function decline following laparoscopic radical nephroureterectomy Toru KannoGo KoboriHitoshi Yamada Original Article 06 February 2024 Pages: 464 - 472
First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the effectiveness using real-world data Hiroki IshiharaKenji OmaeToshio Takagi Original Article 12 February 2024 Pages: 473 - 480
Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy Honami SatoTakahiro KobayashiNaoto Takahashi Original Article Open access 09 February 2024 Pages: 481 - 492